CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression K Fousek, J Watanabe, SK Joseph, A George, X An, TT Byrd, JS Morris, ... Leukemia 35 (1), 75-89, 2021 | 138 | 2021 |
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2 X An, M Martinez-Paniagua, A Rezvan, SR Sefat, M Fathi, S Singh, ... Iscience 24 (9), 2021 | 73 | 2021 |
Single-cell profiling of dynamic cytokine secretion and the phenotype of immune cells X An, VG Sendra, I Liadi, B Ramesh, G Romain, C Haymaker, ... PLoS One 12 (8), e0181904, 2017 | 47 | 2017 |
Single-cell cloning of breast cancer cells secreting specific subsets of extracellular vesicles M Fathi, R Joseph, JRT Adolacion, M Martinez-Paniagua, X An, ... Cancers 13 (17), 4397, 2021 | 19 | 2021 |
Targeting primary pre-B cell acute lymphoblastic leukemia and CD19-negative relapses using trivalent CAR T cells K Fousek, J Watanabe, A George, X An, H Samaha, SA Navai, TT Byrd, ... Blood 130, 4614, 2017 | 19 | 2017 |
Designed improvement to T-cell immunotherapy by multidimensional single cell profiling IN Bandey, JRT Adolacion, G Romain, MM Paniagua, X An, A Saeedi, ... Journal for immunotherapy of cancer 9 (3), 2021 | 14 | 2021 |
Single-cell technologies for profiling T cells to enable monitoring of immunotherapies X An, N Varadarajan Current opinion in chemical engineering 19, 142-152, 2018 | 10 | 2018 |
Targeting CD19-negative relapsed B-acute lymphoblastic leukemia using trivalent CAR T cells. K Fousek, J Watanabe, A George, X An, HS Samaha, SA Navai, TT Byrd, ... Journal of Clinical Oncology 36 (5_suppl), 121-121, 2018 | 9 | 2018 |
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2. iScience. 2021; 24 (9): 103037 X An, M Martinez-Paniagua, A Rezvan, SR Sefat, M Fathi, S Singh, ... CrossRef CAS PubMed PubMed Central, 2021 | 5 | 2021 |
CAR+ T cell anti-tumor efficacy revealed by multi-dimensional single-cell profiling X An, G Romain, M Martinez-Paniagua, IN Bandey, JRT Adolacion, ... The Journal of Immunology 202 (1_Supplement), 134.2-134.2, 2019 | 2 | 2019 |
T-cell potential for CD19-expressing malignancies revealed by multi-dimensional single-cell profiling A Rezvan, G Romain, M Fathi, D Heeke, M Martinez-Paniagua, X An, ... bioRxiv, 2022.06. 22.497245, 2022 | 1 | 2022 |
Abstract A50: Trivalent CAR T cells mitigate CD19-negative relapse and improve tumor control in primary pre-B cell acute lymphoblastic leukemia (B-ALL) K Fousek, J Watanabe, X An, A George, H Samaha, S Navai, TT Byrd, ... Cancer Immunology Research 6 (9_Supplement), A50-A50, 2018 | 1 | 2018 |
EVOLVE-105, a differentiated CD20-targeted CD2 co-stimulatory T cell engager engineered for the treatment of B cell malignancies X An, M Sarkar, S Martomo, M Hackett, G Jin, T Liang, D Klaskin, T Lichter, ... Cancer Research 84 (6_Supplement), 2369-2369, 2024 | | 2024 |
Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition MJ Montalvo, IN Bandey, A Rezvan, KL Wu, A Saeedi, R Kulkarni, Y Li, ... Cell Death & Disease 15 (2), 109, 2024 | | 2024 |
1392 EVOLVE-104, a novel ULBP2-targeted T cell engager that integrates CD2 costimulation for the treatment of basal and squamous lineage tumors EM Tam, M Sarkar, G Jin, OA Sergeeva, A Abulizi, Z Lai, H Karp, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
Enhanced CRISPR-Cas9 edited CAR-T cells through simultaneous inactivation of multiple T cell exhaustion pathways O Sergeeva, A Fearnley, SS Chin, X An, NA Pels, K Metzler, K Joinville, ... Cancer Research 83 (7_Supplement), 4094-4094, 2023 | | 2023 |
EVOLVETM: A novel T cell engager platform with integrated CD2 costimulation engineered for the treatment of immune suppressive tumors M Sarkar, EM Tam, G Jin, SS Chin, A Abulizi, OA Sergeeva, Z Lai, E Teran, ... Cancer Research 83 (7_Supplement), 2971-2971, 2023 | | 2023 |
Abstract B44: EVOLVE: A novel costimulatory T cell engager platform engineered for the treatment of solid tumors MSS Chin, M Sarkar, E Tam, A Abulizi, G Jin, X An, E Teran, DM Klaskin, ... Cancer Immunology Research 10 (12_Supplement), B44-B44, 2022 | | 2022 |
402 T cell killing is facilitated by multiple cytotoxic pathways M Montalvo, I Bandey, A Rezvan, KL Wu, A Saeedi, Y Li, R Kulkarni, X An, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
Metabolic plasticity of T-cell therapies: multi-omic profiling of interacting human tumor-infiltrating lymphocytes and autologous tumor adoptive cell therapy M Martinez-Paniagua, C Haymaker, J Robinson, M Harel, C Creasy, ... bioRxiv, 2022.09. 28.509590, 2022 | | 2022 |